Alteraciones inmunológicas en la Enfermedad de Castleman

Alfonso Valdés, María Elena; Fernández Aguila, Julio D; del Valle Pérez, Lázaro O; Bencomo Hernández, Antonio; Macías Abraham, Consuelo.
Rev. cuba. hematol. inmunol. hemoter ; 30(2): 184-189, abr.-jun. 2014.
Artículo en Español | CUMED | ID: cum-57241

Documentos relacionados

  1. Multicentric Castlemans disease. Symptoms, diagnostics and therapy.
  2. Insights into the etiology of Castleman disease.
  3. The experience of diagnosis and treatment for TAFRO syndrome.
  4. Diagnosis and Management of Castleman Disease.
  5. Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival.
  6. Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease.
  7. The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease.
  8. An unusual cause of ascites: Castleman disease.
  9. The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registry.
  10. Multicentric Castleman disease and the evolution of the concept.